At this time, posts about Enzychem Lifesciences are rapidly increasing on portals and securities communities, and today, foreigners are tentatively estimated to have net purchased 2,000 shares. Enzychem Lifesciences is known as a global new drug development and active pharmaceutical ingredient company.

As of 12:30 PM on the 12th, Enzychem Lifesciences' stock price is 143,400 KRW, down 7.66% from the previous day, with a trading volume of 404,579 shares, which is 39.33% of the 5-day average trading volume. On August 7th, Enzychem Lifesciences was an issue in the market for "rising trend due to FDA approval of Phase 2 clinical trial for COVID-19 treatment."

In addition to Enzychem Lifesciences, posts by investors are also rapidly increasing regarding Shinil Pharmaceutical (012790), Hanwha Life Insurance (088350), and Wonpoong Trading (008290).

※Source: AI Investment Assistant AI Lassi

※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing